Views & Analysis Breaking policy and perceptual barriers: Biosimilars Experts from Research Partnership analyse the company’s Therapy Watch data to identify how market access policy has impacted the adoption of biosimilars.
Views & Analysis Digital health and pharma – adapting to the post-coronavirus... The need for digital transformation and a response model for coronavirus were among the topics discussed in a recent digital debate
Views & Analysis 6 ways to digitise your business at pace As the COVID-19 pandemic stretches on, can your business survive without face-to-face customer contact?
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.